| Prophylactic treatment (primary prevention) | LVEF ≤ 35% and NYHA class II-III symptoms after myocardial infarction (≥ 40 days) |
| LVEF ≤ 30% and NYHA class I symptoms after myocardial infarction (≥ 40 days) | |
| Nonsustained VT and LVEF ≤ 40% after myocardial infarction, as well as sustained VT or VF during electrophysiological examination | |
| LVEF ≤ 35% and NYHA class II-III symptoms or syncope in dilated cardiomyopathy | |
| If considered appropriate by a specialist physician in other structural heart diseases (e.g. hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy) and in inherited, potentially life-threatening ion-channel abnormalities (e.g. long QT syndrome, Brugada syndrome, catecholamine-sensitive polymorphic VT) | |
| Treatment post cardiac arrest (secondary prevention) | VT or VF induced cardiac arrest not due to a treatable or reversible cause, even if the heart is structurally normal |
| Sustained VT in a patient with a structural heart disease, irrespective of the left ventricular function | |
| Unexplained syncope, as well as sustained VT or VF triggered during an electrophysiological examination |
| LVEF = left ventricular ejection fraction; VT = ventricular tachycardia; VF = ventricular fibrillation | ||||||||||||||||||
Prophylactic treatment, i.e. primary prevention
Treatment post cardiac arrest, i.e. secondary prevention
Contraindications to ICD therapy
Implantation of an ICD and patient monitoringImplantation of an ICD
Follow-up at the pacemaker clinic
Follow-up in primary care
Indications for pacemaker clinic consultationICD function
ICD malfunction
Interference caused by household appliances and other equipment
Treatment of arrhythmias in patients with an ICD
The effect of an ICD on everyday life
| ||||||||||||||||||
Primary/Secondary Keywords